Maintenance therapy with colloidal bismuth subcitrate in duodenal ulcer disease
- PMID: 3305118
- DOI: 10.1159/000199558
Maintenance therapy with colloidal bismuth subcitrate in duodenal ulcer disease
Abstract
Various investigators have reported that relapses after healing of duodenal ulcers with colloidal bismuth subcitrate (CBS, De-Nol) occur less frequently than after healing with H2-antagonists. To date, treatment with CBS has been limited to 8 weeks. After a volunteer study showed that prolonged administration of CBS did not cause safety problems, a trial was undertaken in which the effects of additional maintenance CBS treatment with 120 mg of CBS daily is compared with placebo. Interim results showed that after 6 months endoscopically confirmed relapse occurred in 5 (38.5%) of the 13 patients as compared to 12 (80%) of the 15 placebo-treated patients (p = 0.05). Besides 3 cases of transient constipation, no side effects, neurological, biochemical or hematological changes were observed.
Similar articles
-
Combination treatment: colloidal bismuth subcitrate with H2-antagonists.Digestion. 1987;37 Suppl 2:42-6. doi: 10.1159/000199557. Digestion. 1987. PMID: 2887475 Clinical Trial.
-
A comparison of colloidal bismuth subcitrate tablets and ranitidine in the treatment of chronic duodenal ulcers.Digestion. 1986;34(3):173-7. doi: 10.1159/000199326. Digestion. 1986. PMID: 3530861 Clinical Trial.
-
A comparative study of colloidal bismuth subcitrate and cimetidine on the healing and recurrence of duodenal ulcer.Scand J Gastroenterol Suppl. 1982;80:23-30. Scand J Gastroenterol Suppl. 1982. PMID: 6761849 Clinical Trial.
-
The influence of colloidal bismuth subcitrate on duodenal ulcer relapse.Scand J Gastroenterol Suppl. 1986;122:35-8. doi: 10.3109/00365528609102584. Scand J Gastroenterol Suppl. 1986. PMID: 3535020 Review.
-
Colloidal bismuth in the treatment of duodenal ulceration: the benefit for the patient.Scand J Gastroenterol Suppl. 1989;157:16-20; discussion 21-2. doi: 10.3109/00365528909091046. Scand J Gastroenterol Suppl. 1989. PMID: 2568684 Review.
Cited by
-
Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.Drugs. 1988 Aug;36(2):132-57. doi: 10.2165/00003495-198836020-00002. Drugs. 1988. PMID: 3053124 Review.
-
A risk-benefit assessment of drugs used in the eradication of Helicobacter pylori infection.Drug Saf. 1996 Jul;15(1):30-52. doi: 10.2165/00002018-199615010-00003. Drug Saf. 1996. PMID: 8862962 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources